Literature DB >> 1180616

The mechanism of action of amantadine in Parkinsonism: a review.

E V Bailey, T W Stone.   

Abstract

Studies of the mechanism of action of amantadine are reviewed. Data from pharmacological, behavioural and neurochemical experiments seem to indicate that the most likely effects of amantadine to be important in the alleviation of Parkinsonian symptoms are an indirect dopamine-releasing action and a direct stimulation of dopamine receptors. These effects may have a relative importance of approximately 4 : 1. Evidence favouring inhibition of dopamine uptake does exist, but the balance of opinion seems to be that this action is far too weak to contribute substantially to amantadine's action in vivo.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1180616

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  12 in total

Review 1.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  New directions in the drug treatment of Parkinson's disease.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

4.  Effects of L-histidine and promethazine on apomorphine and amantadine stereotypy in rats.

Authors:  J J Balsara; B S Dhavare; N V Nandal; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 5.  Early Parkinson's disease: what is the best approach to treatment.

Authors:  A H Hristova; W C Koller
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

6.  Amantadine antagonism of oxotremorine effects.

Authors:  Y Eshel; A D Korczyn
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Adamantane derivatives: a new class of insulin secretagogues.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

8.  Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.

Authors:  M K Menon; C A Vivonia; V G Haddox
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain.

Authors:  K Toide
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 10.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.